AJTMH ASTMH Job Mart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 60(2), 1999, pp. 244-247
Copyright © 1999 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koopmans, R
Right arrow Articles by De Vries, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koopmans, R
Right arrow Articles by De Vries, P.
Related Collections
Right arrow Malaria
Right arrow Plasmodium
American Journal of Tropical Medicine and Hygiene, Vol 60, Issue 2, 244-247
Copyright © 1999 by American Society of Tropical Medicine and Hygiene

Research Articles


The pharmacokinetics of artemisinin after administration of two different suppositories to healthy Vietnamese subjects

R Koopmans, LD Ha, DD Duc, TK Dien, PA Kager, NX Khanh, CJ van Boxtel, and PJ De Vries

Eight healthy Vietnamese male subjects received 400 mg artemisinin formulated into fatty suppositories (FS), and six different subjects received 500 mg of artemisinin formulated in polyethylene glycol suppositories (PEGS). Plasma concentrations were measured by high-performance liquid chromatography with electrochemical detection; concentration versus time curves were analyzed with nonparametric methods. No statistically significant differences were found between the two formulations. The maximum concentration (Cmax) was 100 +/- 102 microg/L (mean +/- SD, range = 24-330) microg/L (FS), the pharmacokinetic lag time (Tlag) was 1.3 +/- 1.0 hr (range = 0-3) (FS), and the time of the maximum concentration (Tmax) was 7.1 +/- 2.1 hr (range = 3-10) hr (FS). Because artemisinin is not available for intravenous dosage, absolute bioavailability cannot be assessed. However, compared with a previous study on oral artemisinin in healthy Vietnamese subjects, bioavailability relative to oral administration was estimated to be approximately 30%. We conclude that therapeutic blood concentrations of artemisinin can be reached after rectal dosage. The dose after rectal administration should probably be higher than after oral administration; doubling or tripling the oral dose might be necessary, which would imply a rectal dose of at least 20 mg/kg of body weight given twice a day.


This article has been cited by other articles:


Home page
 JAMAHome page
H. A. Karunajeewa, L. Manning, I. Mueller, K. F. Ilett, and T. M. E. Davis
Rectal Administration of Artemisinin Derivatives for the Treatment of Malaria
JAMA, June 6, 2007; 297(21): 2381 - 2390.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
A.-C. Egnell, J. B. Houston, and C. S. Boyer
Predictive Models of CYP3A4 Heteroactivation: In Vitro-in Vivo Scaling and Pharmacophore Modeling
J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 926 - 937.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
C J Woodrow, R K Haynes, and S Krishna
Artemisinins
Postgrad. Med. J., February 1, 2005; 81(952): 71 - 78.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Society of Tropical Medicine and Hygiene.